IMPORTANCE Acute kidney injury (AKI) after percutaneous coronary intervention (PCI) is common, morbid, and costly; increases patients' mortality risk; and can be mitigated by limiting contrast use.
A cute kidney injury (AKI) after percutaneous coronary intervention (PCI) is common, occurring in 7% of patients, 1 ,2 but is a severely morbid and costly event that increases the risk of dialysis and mortality. [1] [2] [3] [4] Because hydration has modest benefit and administration of sodium bicarbonate and N-acetylcysteine has not proved to be effective in preventing AKI, 5-7 reducing contrast volume may be the most effective strategy for preventing AKI. 8 Despite the morbidity and mortality of AKI, little is known about physician variation in contrast use in the United States and its association with AKI. A previous study found marked variation in AKI incidence rates directly associated with hospitals 9 but did not examine the variability in physicians'
use of contrast, which is a modifiable factor for preventing AKI. We hypothesized that if physician variation in AKI incidence and contrast volumes exists, it would highlight an important opportunity to improve PCI safety. Using the National Cardiovascular Data Registry (NCDR) CathPCI Registry, we examined (1) the variation in AKI rates among physicians, (2) the variation in physicians' use of contrast, and (3) the association of contrast use with patients' AKI risk.
Methods

Study Population
The NCDR CathPCI Registry has been previously described. 
Factors and Outcomes
The primary outcome of AKI was defined as the change from preprocedure creatinine levels to peak creatinine levels according to the Acute Kidney Injury Network criteria as an absolute increase of 0.3 mg/dL or more or as a relative increase of 50% or more from preprocedural to peak creatinine. A secondary outcome was the physicians' mean contrast volume. This analysis was limited to physicians performing 50 or more PCIs. Glomerular filtration rate was estimated using the Modification of Diet in Renal Disease Study equation, 11 and the preprocedural AKI risk was calculated from a previously validated NCDR CathPCI Registry model. 
Key Points
Question What is the variation in contrast volume and acute kidney injury incidence among US physicians after performing percutaneous coronary intervention?
Findings In this cross-sectional study involving more than 1.3 million patients who underwent percutaneous coronary intervention, a large variation in acute kidney injury incidence and contrast use was observed among physicians who performed the procedures. There was no evidence that physicians used significantly less contrast in patients at higher risk of acute kidney injury.
Meaning
The variation among physicians and the absence of an adjustment in contrast volume for patients at higher risk for acute kidney injury underscores an important opportunity to reduce acute kidney injury. a more stringent definition of AKI as a creatinine level of 0.5 mg/dL or higher (to convert to micromoles per liter, multiply by 88.4). 
Results
Demographic and Clinical Characteristics
Physician Variation in AKI Rate and Contrast Volume
We observed wide variation in AKI rates across physicians from 0% to 30% ( Figure 1A) . When adjusted for patient characteristics and AKI risk, we found significant variation in AKI rates across physicians (MOR, 1.43; 95% CI, 1.41-1.44; P < .001), implying a mean 43% excess AKI risk for statistically identical patients treated by 2 random physicians. We observed significant variation in physicians' mean contrast volume (range, 79-487 mL) ( Figure 1B ). When adjusted for patient characteristics and accounting for differences across physicians, we found a significant variation in contrast volumes across physicians (ICC, 0.23; interquartile range, 0.21-0.25; P < .001), implying that 23% of the variation in contrast volume was directly explained by physicians rather than by patient characteristics.
Association of Contrast Volume With AKI Rates
As expected, higher contrast use was associated with higher AKI rates (eFigure 1 in the Supplement). Physicians who used more contrast had an odds ratio of 1.42 (95% CI, 1.40-1.43) per incremental 75-mL increase in contrast use (P < .001) after adjusting for patient characteristics and AKI risk. Thus, every incremental 75 mL of contrast used increased the risk of AKI by 42%. A scatterplot (eFigure 2 in the Supplement) demonstrates that physicians who used more contrast had patients with a higher rate of observed AKI.
Association of Patients' AKI Risk With Contrast Use
Unlike the expectation that patients with higher AKI risk would be treated with less contrast, a minimal association was ob- served between patients' AKI risk and contrast volumes (r = −0.054). The contrast used remained fairly constant over deciles 1 to 9 of AKI risk (Figure 2) , with only a minimal (16-mL) mean reduction in the highest risk decile.
Sensitivity Analysis
Approximately 675 000 patients (50%) belonged to the highcomplexity cohort. Sensitivity analysis of physician variation in AKI in the high PCI complexity vs low PCI complexity groups showed that the MOR for the low PCI complexity cohort was 1.45 (95% CI, 1.43-1.48) and for the high PCI complexity cohort was 1.41 (95% CI, 1.39-1.43). Thus, physician variation in AKI remained essentially unchanged by PCI complexity. Additional sensitivity analyses by overnight stay vs same-day discharge, physicians' even vs odd National Provider Identifier number, and a more stringent definition of AKI as 0.5 mg/dL or higher showed that the physician variation in AKI and contrast remained unchanged.
Discussion
Acute kidney injury is a serious complication of PCI that is associated with high morbidity, mortality, length of stay, and costs. To our knowledge, this study of more than 1.3 million patients on the NCDR CathPCI Registry is the first that highlights an important opportunity for reducing contrast use and AKI. We observed a large variation in AKI rates and contrast volume among physicians, independent of patient factors. Unlike the expectation that patients with higher risk of AKI would be treated with less contrast, we found a minimal reduction of contrast volumes in patients with higher risk of AKI. In addition, we found that the physician variation in AKI did not change by PCI complexity, implying that variation in AKI is attributable to physician practices rather than case complexity. Thus, our study lays the foundation for national efforts to reduce AKI rates by extending the strategies of Brown et al 15 and by providing clinicians with safe contrast volumes prior to PCI procedures.
17,18
We can surmise that variation in contrast volumes is perhaps associated with frequent injections, ventriculograms, larger bore guides, trainees' involvement, multivessel PCI without staging the second or third vessel, and variation in interventional techniques of wiring lesions and balloon and stent placement, which all consume contrast. A qualitative study is needed on such interventional practices and the potential unintended consequences of efforts to reduce contrast. The AKI risk is calculated by using variables from the parsimonious AKI risk prediction model 1 : sociodemographic characteristics (age, sex, and race), clinical risk factors (prior myocardial infarction, percutaneous coronary intervention, bypass surgery or heart failure, diabetes, cerebrovascular disease, lung disease, tobacco use, dyslipidemia, hypertension, and baseline chronic kidney disease stage), and other disease severity characteristics (stable angina, unstable angina, non-ST-elevation myocardial infarction or ST-elevation myocardial infarction, acute heart failure, cardiogenic shock, and use of a balloon pump). 
Conclusions
We found that AKI rates and contrast volumes vary substantially among physicians. A significant proportion of this variation was associated with differences in contrast use. Moreover, there was little evidence that physicians were limiting the amount of contrast in patients at higher risk for AKI. Furthermore, the physician variation in AKI incidence remained unchanged after excluding complex cases. This study underscores an important opportunity to reduce AKI by reducing the variation in contrast volumes used by physicians across US centers. 
